Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine

J Thorac Dis. 2018 Mar;10(3):1364-1369. doi: 10.21037/jtd.2018.03.97.

Authors

Peng Shen¹, Wenzhao Zhong²

Affiliations

¹ Department of Oncology, Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
² Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

No abstract available

Publication types

Editorial
Comment